![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
Amongst the unanswered questions regarding prostate cancer (PCa), the optimal management of oligometastatic disease remains one of the major concerns of the scientific community. The very existence of this cat...
-
Article
Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
Corticosteroid agents (CA) are widely used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) either as concomitant treatment with active agents such as docetaxel, cabazitaxel and abir...
-
Article
A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer
Focal therapy is an emerging mini-invasive treatment modality for localized prostate cancer aimed to reduce the morbidity associated with radical therapy while maintaining optimal cancer control. We report the...